Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 1000275 TORONTO, A6
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,795,017
+$1,058,855 QoQ
Shares Held
103,162
+32.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 334 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. FTRE ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in FTRE

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,795,017 103,162
2026-03-31 $736,162 78,149
2025-12-31 $4,791,479 277,767
2025-09-30 $1,981,921 235,383
2025-06-30 $2,596,816 525,672
2025-03-31 $918,885 121,707
2024-12-31 $1,524,877 81,763
2024-09-30 $1,655,180 82,759
2024-06-30 $2,805,885 120,218
2024-03-31 $4,543,040 113,180
2023-12-31 $4,206,459 120,529
2023-09-30 $3,583,067 125,326
2023-06-30 $739,819 21,753